Oncotarget

Vol 11, No 40

October 6, 2020

View Archive »

Order a Reprint

About The Cover

The cover for issue 40 of Oncotarget features Figure 5, "miR-210 silences the proapoptosis member CASP8AP2," by Kling, et al.

Table of Contents

Meeting Reports

Deconstructing tumor heterogeneity: the stromal perspective

Deconstructing tumor heterogeneity: the stromal perspective

https://doi.org/10.18632/oncotarget.27736

Renee E. Vickman, Douglas V. Faget, Philip Beachy, David Beebe, Neil A. Bhowmick, Edna Cukierman, Wu-Min Deng, James G. Granneman, Jeffrey Hildesheim, Raghu Kalluri, Ken S. Lau, Ernst Lengyel, Joakim Lundeberg, Jorge Moscat, Peter S. Nelson, Kristian Pietras, Katerina Politi, Ellen Puré, Ruth Scherz-Shouval, Mara H. Sherman, David Tuveson, Ashani T. Weeraratna, Richard M. White, Melissa H. Wong, Elisa C. Woodhouse, Ying Zheng, Simon W. Hayward,  and Sheila A. Stewart
3621-3632
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Research Papers

Exosomes secreted under hypoxia enhance stemness in Ewing’s sarcoma through miR-210 delivery

Exosomes secreted under hypoxia enhance stemness in Ewing’s sarcoma through miR-210 delivery

https://doi.org/10.18632/oncotarget.27702

Matthew J. Kling, Nagendra K. Chaturvedi, Varun Kesherwani, Don W. Coulter, Timothy R. McGuire, J. Graham Sharp,  and Shantaram S. Joshi
3633-3645
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Podcast  |  Order a Reprint

The pro-apoptotic actions of 2-methoxyestradiol against ovarian cancer involve catalytic activation of PKCδ signaling

The pro-apoptotic actions of 2-methoxyestradiol against ovarian cancer involve catalytic activation of PKCδ signaling

https://doi.org/10.18632/oncotarget.27760

Purab Pal, Karen Hales,  and Dale Buchanan Hales
3646-3659
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Simvastatin is a potential candidate drug in ovarian clear cell carcinomas

Simvastatin is a potential candidate drug in ovarian clear cell carcinomas

https://doi.org/10.18632/oncotarget.27747

Nicolai Skovbjerg Arildsen,  and Ingrid Hedenfalk
3660-3674
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Neuroendocrine carcinoma of uterine cervix findings shown by MRI for staging and survival analysis – Japan multicenter study

Neuroendocrine carcinoma of uterine cervix findings shown by MRI for staging and survival analysis – Japan multicenter study

https://doi.org/10.18632/oncotarget.27613

Kazuhiro Kitajima, Takako Kihara, Yusuke Kawanaka, Aki Kido, Kotaro Yoshida, Yasunari Mizumoto, Akiko Tomiyama, Shigeo Okuda, Masahiro Jinzaki, Fumi Kato, Junko Takahama, Akiko Takahata, Yoshihiko Fukukura, Atsushi Nakamoto, Tetsuya Tsujikawa, Jiro Munechika, Yoshimitstu Ohgiya, Nobuyuki Kawai, Satoshi Goshima, Ayumi Ohya, Yasunari Fujinaga, Takeru Fukunaga, Shinya Fujii, Masahiro Tanabe, Katsuyoshi Ito, Takahiro Tsuboyama, Yuichiro Kanie, Shigeaki Umeoka, Shintaro Ichikawa, Utaroh Motosugi, Sayaka Daido, Ayumu Kido, Tsutomu Tamada, Mitsuru Matsuki, Tsuneo Yamashiro,  and Koichiro Yamakado
3675-3686
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Order a Reprint

Corrections

Correction: Inhibition of fibroblast secreted QSOX1 perturbs extracellular matrix in the tumor microenvironment and decreases tumor growth and metastasis in murine cancer models

Correction: Inhibition of fibroblast secreted QSOX1 perturbs extracellular matrix in the tumor microenvironment and decreases tumor growth and metastasis in murine cancer models

https://doi.org/10.18632/oncotarget.27764

Tal Feldman, Iris Grossman-Haham, Yoav Elkis, Patrick Vilela, Neta Moskovits, Iris Barshack, Tomer M. Salame, Deborah Fass,  and Tal Ilani
3687-3687
Correction  |  PDF  |  How to cite


Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC